280 related articles for article (PubMed ID: 29758942)
1. Lost in Translation? Finding Our Way To Effective Alzheimer's Disease Therapies.
Quinn JF
J Alzheimers Dis; 2018; 64(s1):S33-S39. PubMed ID: 29758942
[TBL] [Abstract][Full Text] [Related]
2. Translation of Pre-Clinical Studies into Successful Clinical Trials for Alzheimer's Disease: What are the Roadblocks and How Can They Be Overcome?
Banik A; Brown RE; Bamburg J; Lahiri DK; Khurana D; Friedland RP; Chen W; Ding Y; Mudher A; Padjen AL; Mukaetova-Ladinska E; Ihara M; Srivastava S; Padma Srivastava MV; Masters CL; Kalaria RN; Anand A
J Alzheimers Dis; 2015; 47(4):815-43. PubMed ID: 26401762
[TBL] [Abstract][Full Text] [Related]
3. Overcoming translational barriers impeding development of Alzheimer's disease modifying therapies.
Golde TE
J Neurochem; 2016 Oct; 139 Suppl 2(Suppl 2):224-236. PubMed ID: 27145445
[TBL] [Abstract][Full Text] [Related]
4. Measuring target effect of proposed disease-modifying therapies in Alzheimer's disease.
Bateman RJ; Klunk WE
Neurotherapeutics; 2008 Jul; 5(3):381-90. PubMed ID: 18625449
[TBL] [Abstract][Full Text] [Related]
5. Alzheimer's therapeutics: translation of preclinical science to clinical drug development.
Savonenko AV; Melnikova T; Hiatt A; Li T; Worley PF; Troncoso JC; Wong PC; Price DL
Neuropsychopharmacology; 2012 Jan; 37(1):261-77. PubMed ID: 21937983
[TBL] [Abstract][Full Text] [Related]
6. Prevention Trials in Alzheimer's Disease: Current Status and Future Perspectives.
Wang J; Tan L; Yu JT
J Alzheimers Dis; 2016; 50(4):927-45. PubMed ID: 26836177
[TBL] [Abstract][Full Text] [Related]
7. The biomarker and therapeutic potential of miRNA in Alzheimer's disease.
Bekris LM; Leverenz JB
Neurodegener Dis Manag; 2015; 5(1):61-74. PubMed ID: 25711455
[TBL] [Abstract][Full Text] [Related]
8. Challenges in Alzheimer's Disease Drug Discovery and Development: The Role of Modeling, Simulation, and Open Data.
Conrado DJ; Duvvuri S; Geerts H; Burton J; Biesdorf C; Ahamadi M; Macha S; Hather G; Francisco Morales J; Podichetty J; Nicholas T; Stephenson D; Trame M; Romero K; Corrigan B;
Clin Pharmacol Ther; 2020 Apr; 107(4):796-805. PubMed ID: 31955409
[TBL] [Abstract][Full Text] [Related]
9. Clinical Trials for Disease-Modifying Therapies in Alzheimer's Disease: A Primer, Lessons Learned, and a Blueprint for the Future.
Cummings J; Ritter A; Zhong K
J Alzheimers Dis; 2018; 64(s1):S3-S22. PubMed ID: 29562511
[TBL] [Abstract][Full Text] [Related]
10. Beyond immunotherapy: new approaches for disease modifying treatments for early Alzheimer's disease.
Ruthirakuhan M; Herrmann N; Suridjan I; Abraham EH; Farber I; Lanctôt KL
Expert Opin Pharmacother; 2016 Dec; 17(18):2417-2429. PubMed ID: 27825018
[TBL] [Abstract][Full Text] [Related]
11. The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer's disease.
Ritchie CW; Russ TC; Banerjee S; Barber B; Boaden A; Fox NC; Holmes C; Isaacs JD; Leroi I; Lovestone S; Norton M; O'Brien J; Pearson J; Perry R; Pickett J; Waldman AD; Wong WL; Rossor MN; Burns A
Alzheimers Res Ther; 2017 Oct; 9(1):85. PubMed ID: 29070066
[TBL] [Abstract][Full Text] [Related]
12. Translational Assays for Assessment of Cognition in Rodent Models of Alzheimer's Disease and Dementia.
Shepherd A; Tyebji S; Hannan AJ; Burrows EL
J Mol Neurosci; 2016 Nov; 60(3):371-382. PubMed ID: 27637601
[TBL] [Abstract][Full Text] [Related]
13. Alzheimer's disease research and development: a call for a new research roadmap.
Feldman HH; Haas M; Gandy S; Schoepp DD; Cross AJ; Mayeux R; Sperling RA; Fillit H; van de Hoef DL; Dougal S; Nye JS;
Ann N Y Acad Sci; 2014 Apr; 1313():1-16. PubMed ID: 24754377
[TBL] [Abstract][Full Text] [Related]
14. Photobiomodulation for Alzheimer's Disease: Translating Basic Research to Clinical Application.
Enengl J; Hamblin MR; Dungel P
J Alzheimers Dis; 2020; 75(4):1073-1082. PubMed ID: 32390621
[TBL] [Abstract][Full Text] [Related]
15. Boosting translational research on Alzheimer's disease in Europe: The Innovative Medicine Initiative AD research platform.
Vaudano E; Vannieuwenhuyse B; Van Der Geyten S; van der Lei J; Visser PJ; Streffer J; Ritchie C; McHale D; Lovestone S; Hofmann-Apitius M; Truyen L; Goldman M
Alzheimers Dement; 2015 Sep; 11(9):1121-2. PubMed ID: 25754460
[No Abstract] [Full Text] [Related]
16. New and emerging treatments for Alzheimer's disease.
Corbett A; Smith J; Ballard C
Expert Rev Neurother; 2012 May; 12(5):535-43. PubMed ID: 22550982
[TBL] [Abstract][Full Text] [Related]
17. Emerging concepts towards a translational framework in Alzheimer's disease.
Cozachenco D; Zimmer ER; Lourenco MV
Neurosci Biobehav Rev; 2023 Sep; 152():105246. PubMed ID: 37236385
[TBL] [Abstract][Full Text] [Related]
18. We can treat Alzheimer's disease successfully in mice but not in men: failure in translation? A perspective.
Windisch M
Neurodegener Dis; 2014; 13(2-3):147-50. PubMed ID: 24401335
[TBL] [Abstract][Full Text] [Related]
19. Obstacles and opportunities in Alzheimer's clinical trial recruitment.
Watson JL; Ryan L; Silverberg N; Cahan V; Bernard MA
Health Aff (Millwood); 2014 Apr; 33(4):574-9. PubMed ID: 24711317
[TBL] [Abstract][Full Text] [Related]
20. Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative.
Veitch DP; Weiner MW; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Morris JC; Petersen RC; Saykin AJ; Shaw LM; Toga AW; Trojanowski JQ;
Alzheimers Dement; 2019 Jan; 15(1):106-152. PubMed ID: 30321505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
